Literature DB >> 3312668

Immunodeficiency diseases.

R H Buckley.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3312668

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Postinfection therapy of arbovirus infections in mice.

Authors:  I P Singh; D H Coppenhaver; M Sarzotti; P Sriyuktasuth; J Poast; H B Levy; S Baron
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 2.  Asthma. A role for IVIG therapy?

Authors:  P Fireman; G Friday
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

3.  In vitro synthesis of human IgE is suppressed by human IgG.

Authors:  H Haas; M Schlaak
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

4.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

Review 5.  Cellular and molecular basis of immunodeficiencies: their consequences for the development and induction of the immune response.

Authors:  J Sterzl
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

6.  Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.

Authors:  A Saxon; E Macy; K Denis; M Tary-Lehmann; O Witte; J Braun
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.

Authors:  J P DiSanto; C A Keever; T N Small; G L Nicols; R J O'Reilly; N Flomenberg
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.